Apelis Pharmaceuticals (APLS, +1) – Timothy Sullivan (CFO since 2017; Board observer 2014-2017) purchased 11,699 shares on August 29 at $29.71, spending $347,000 in his first purchase in the stock. Sullivan has been involved with this company since 2014, and CFO since 2017. It is unusual to see him make his first purchase now, especially after the stock has moved up to a recent multi-year high. We did not find ownership requirements listed in the proxy prompting the purchase. Sullivan owns 165,000 options in addition to the shares he just purchased. We are ranking the stock +1 based on this large “out of the blue” purchase from the CFO.